|
Prior to co-founding Thomas, McNerney & Partners, James led E.M. Warburg, Pincus & Co., L.L.C.'s health care technology private equity practice. During his 12-year tenure at Warburg, he was directly involved in portfolio company investments totaling over $450 million, including investments in American Medical Systems Holdings, Inc. (AMMD), The Medicines Company (MDCO), NeXagen, Inc. (NXGN/NXTR), Oxford GlycoSciences, plc (OGSI), Transkaryotic Therapies, Inc. (TKTX), Wright Medical Group, Inc. (WMGI) and Xomed Surgical Products, Inc. (XOMD). James is currently a board member of Clarus Therapeutics, Inc., Coley Pharmaceutical Group, OsteoBiologics, Inc., Solstice Neurosciences and Wright Medical Group, Inc. Prior to joining Warburg, he was a Vice President at Goldman Sachs International in London, England. James graduated magna cum laude with a B.S. from the Wharton School at the University of Pennsylvania and received an M.Sc. from the London School of Economics. | 